4Cooper ME,Mundel P, Boner G. Role of nephrin in renal disease including diabetes nephropathy[J]. Semin Nephrol,2002,22 (5) : 393 -398.
5Wolf G, Ritz E. Diabetic Nephropathy in type 2 diabetes prevention and patientmanagement [ J ]. Am Soc Nephrol, 2003, 14 ( 5 ) : 1396-1405.
6Huang CC,Jinn YG, Shyi JS, et al. Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low- density Lipoprotein [ J ]. Kidney Int, 2001,59 ( Supp 1 ) : s124.
7Evans JL, Goldfine D, Maddux BA, et al. Oxidative stress and stress-actived signaling pathways:a unifying hypothesis of type 2 diabetes[J]. Endocr Rev,2002,23(5) :599-622.
8No authors listed. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [ J ]. N Engl J Med, 1993,329 (14) :977-986.
9No authors listed. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group [ J ]. BMJ, 1998,317(7160) :713-720.
10Lewis EJ,Hunsicker LG,Bain RP,et al. The effect of angiotensin- converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group [J]. N Engl J Med, 1993, 329 (20): 1456-1462.
